Aptadel Therapeutics

A BIOMEDICAL COMPANY FOCUSED ON DEVELOPING AN RNA-BASED PLATFORM OF TARGETED THERAPY DELIVERY TO TREAT CANCER

The Company

Aptadel Therapeutics is a pre-clinical stage drug development biotech company based on RNA Aptamer technology for the treatment of cancer.

Its Aptamer technology is a delivery tool platform for different therapeutic agents (siRNA, miRNA, chemotherapeutic drugs, small molecules…)  that can be used in several indications.

The Company is a spin off from IDIBELL, also co-founded by Fundación Alba. It is based in the Parc Cientific de Barcelona (PCB).